(Q51904272)

English

Atomoxetine versus methylphenidate in paediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial.

scientific article published in March 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464703%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Atomoxetine versus methylphenidate in paediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464703%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

based on heuristic

inferred from title

attention deficit hyperactivity disorder

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464703%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464703%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

7

object named as

Bung N Kim

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464703%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

6

object named as

Soo C Cho

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464703%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Yufeng Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464703%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Yi Zheng

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464703%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Yasong Du

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464703%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Dong H Ahn

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464703%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Maria E Marquez-Caraveo

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464703%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Haitao Gao

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464703%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

David W Williams

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464703%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Louise R Levine

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464703%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 March 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464703%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Australian and New Zealand Journal of Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464703%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

41

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464703%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464703%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

222-230

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464703%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association

1 reference

https://api.crossref.org/works/10.1080%2F00048670601057767

21 January 2018

Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder

1 reference

https://api.crossref.org/works/10.1080%2F00048670601057767

21 January 2018

Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders

1 reference

https://api.crossref.org/works/10.1080%2F00048670601057767

21 January 2018

Long-term outcome of hyperactive children: a review

1 reference

https://api.crossref.org/works/10.1080%2F00048670601057767

21 January 2018

Pharmacotherapy of adult ADHD.

1 reference

https://api.crossref.org/works/10.1080%2F00048670601057767

21 January 2018

Biological effects of central nervous system stimulants

1 reference

https://api.crossref.org/works/10.1080%2F00048670601057767

21 January 2018

Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1080%2F00048670601057767

21 January 2018

Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle

1 reference

https://api.crossref.org/works/10.1080%2F00048670601057767

21 January 2018

Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F00048670601057767

21 January 2018

Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users

1 reference

https://api.crossref.org/works/10.1080%2F00048670601057767

21 January 2018

Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study

1 reference

https://api.crossref.org/works/10.1080%2F00048670601057767

21 January 2018

Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1080%2F00048670601057767

21 January 2018

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies

1 reference

https://api.crossref.org/works/10.1080%2F00048670601057767

21 January 2018

A randomized, placebo-controlled study of once-daily atomoxetine in the school setting in children with ADHD.

1 reference

https://api.crossref.org/works/10.1080%2F00048670601057767

21 January 2018

Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial.

1 reference

https://api.crossref.org/works/10.1080%2F00048670601057767

21 January 2018

Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data

1 reference

https://api.crossref.org/works/10.1080%2F00048670601057767

21 January 2018

Efficacy of atomoxetine versus placebo in school-age girls with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1080%2F00048670601057767

21 January 2018

Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1080%2F00048670601057767

21 January 2018

An open-label trial of tomoxetine in pediatric attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1080%2F00048670601057767

21 January 2018

Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings

1 reference

https://api.crossref.org/works/10.1080%2F00048670601057767

21 January 2018

Effects of atomoxetine on growth after 2-year treatment among pediatric patients with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1080%2F00048670601057767

21 January 2018

Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial

1 reference

https://api.crossref.org/works/10.1080%2F00048670601057767

21 January 2018

Bupropion hydrochloride in attention deficit disorder with hyperactivity.

1 reference

https://api.crossref.org/works/10.1080%2F00048670601057767

21 January 2018

Identifiers

10.1080/00048670601057767

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464703%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464703%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51904272&oldid=1889793300"